SCHEMBL6640724

SCHEMBL6640724

CC(C)CCn1c(=O)c(F)cc2cnc(Nc3ccc(N4CCCC(CO)C4)cc3)cc21

nearest known ligand 0.42

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
SYK P43405 5/20 0.42
BCL6 P41182 1/20 0.42
JAK2 O60674 1/20 0.42
CDK4 P11802 3/20 0.40
CCND1 P24385 3/20 0.40
CCND2 P30279 2/20 0.40
CCND3 P30281 2/20 0.40
FYN P06241 3/20 0.39
SRC P12931 5/20 0.39
BTK Q06187 3/20 0.39
FGFR1 P11362 2/20 0.39
LYN P07948 3/20 0.38
CCNA2 P20248 1/20 0.38
CDK2 P24941 1/20 0.38
WEE1 P30291 1/20 0.38
JAK3 P52333 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6640086 0.90 SRC (0.47) SYKBCL6JAK2CDK4CCND1
SCHEMBL6640656 0.89 FGFR1 (0.47) SYKBCL6JAK2CDK4CCND1
SCHEMBL6639710 0.89 CDK4 (0.48) CDK4CCND1CCND2CCND3FYN
SCHEMBL6639508 0.88 CDK4 (0.49) SYKBCL6JAK2CDK4CCND1
SCHEMBL6641752 0.88 SYK (0.43) SYKBCL6JAK2CDK4CCND1
SCHEMBL6640659 0.88 CDK4 (0.47) CDK4CCND1CCND2CCND3FYN
SCHEMBL6640452 0.86 MAPK8 (0.46) CDK4CCND1CCND2CCND3FYN
SCHEMBL6640998 0.85 CDK4 (0.49) CDK4CCND1CCND2CCND3FYN
SCHEMBL6642010 0.84 CDK4 (0.56) CDK4CCND1CCND2CCND3FYN
SCHEMBL6641963 0.84 CDK4 (0.51) SYKJAK2CDK4CCND1CCND2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1003745-B1 NAPHTHYRIDINONES FOR INHIBITING PROTEIN TYROSINE KINASE AND CELL CYCLE KINASE MEDIATED CELLULAR PROLIFERATION WARNER LAMBERT CO (US) 2004-12-29 EP claimed
US-6150359-A 1,6-NAPHTHYRIDIONE COMPOUNDS USEFUL FOR TREATING CANCER, RESTENOSIS AND ATHEROSCLEROSIS WARNER-LAMBERT COMPANY (US) 2000-11-21 US claimed
EP-1003745-B1 NAPHTHYRIDINONES FOR INHIBITING PROTEIN TYROSINE KINASE AND CELL CYCLE KINASE MEDIATED CELLULAR PROLIFERATION WARNER LAMBERT CO (US) 2004-12-29 EP disclosed
US-6150359-A 1,6-NAPHTHYRIDIONE COMPOUNDS USEFUL FOR TREATING CANCER, RESTENOSIS AND ATHEROSCLEROSIS WARNER-LAMBERT COMPANY (US) 2000-11-21 US disclosed